Pharma Ming Biotechnology Co., Ltd. will hold its Annual General Meeting on June 19, 2024 at Sheraton Shanghai Gaoqiao Hotel. The meeting will discuss resolutions including acceptance of the 2023 audited financial statements and board reports, election of directors, determination of remuneration of directors, renewal and remuneration determination of auditors, share issuance and repurchase authorization. In addition, the Special Resolution will discuss the approval of the fourth revised and revised Articles of Association of the Company. Shareholders will exercise their right to vote by proxy form and must be submitted at least 48 hours prior to the meeting.

Pharma Ming Biotechnology Co., Ltd. will hold its Annual General Meeting on June 19, 2024 at Sheraton Shanghai Gaoqiao Hotel. The meeting will discuss resolutions including acceptance of the 2023 audited financial statements and board reports, election of directors, determination of remuneration of directors, renewal and remuneration determination of auditors, share issuance and repurchase authorization. In addition, the Special Resolution will discuss the approval of the fourth revised and revised Articles of Association of the Company. Shareholders will exercise their right to vote by proxy form and must be submitted at least 48 hours prior to the meeting.